Novo Genomics
PrivateLast Round
Seed
Apr 1, 2022
Company Overview
Novo Genomics is a biotechnology company that provides genomic and multi-omic laboratory services, including DNA sequencing, genetic screening, and oncology diagnostics, to support clinical diagnostics and personalized healthcare.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novo Genomics Comparables
Compare Novo Genomics with similar companies based on industry and business-model similarity.
Novo Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2022 |
Key People
Founding team and executive leadership
Novo Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emkan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Added Propathologyofwy, a pathology startup, as a customer.
Novo Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novo Genomics's valuation, stock price, and market status.